Nov. 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE ... de novo clearance for its Apollo ESG™, Apollo ESG Sx™, Apollo REVISE™ and Apollo REVISE Sx™ Systems, the first ...

The landscape of obesity treatment is quickly changing — and with its acquisition this week of Apollo Endosurgery, medical device maker Boston Scientific is again shaking up the space.

Boston Scientific has laid down a deal to acquire ... This past July, Apollo received de novo clearances from the FDA for its Apollo ESG, Apollo ESG Sx, Apollo REVISE and Apollo REVISE Sx systems ...

Boston Scientific expects the impact to adjusted ... In July 2022, Apollo Endosurgery received FDA de novo clearance for its Apollo ESG, Apollo ESG Sx, Apollo REVISE and Apollo REVISE Sx Systems.

Boston Scientific Corporation BSX recently announced ... In July 2022, Apollo Endosurgery received the FDA de novo clearance for its Apollo ESG, Apollo ESG Sx, Apollo REVISE and Apollo REVISE ...

a medical device maker Boston Scientific, is all set to test its fortunes with the launch of Endoscopic sleeve gastroplasty (ESG) and Intragastric Balloon System (IBS) driven by Apollo and ...

Boston Scientific to acquire Apollo for $10.00 ... the X-Tack® Endoscopic HeliX Tacking System, as well as the Apollo ESG TM, Apollo ESG Sx TM, Apollo REVISE TM and Apollo REVISE Sx TM Systems.

6 In July 2022, Apollo Endosurgery received U.S. Food and Drug Administration (FDA) de novo clearance for its Apollo ESG™, Apollo ... weight management. Boston Scientific expects to complete ...

Nov. 29, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE ... de novo clearance for its Apollo ESG™, Apollo ESG Sx™, Apollo REVISE™ and Apollo REVISE Sx™ Systems, the first devices authorized ...